Document Detail

A prospective clinical trial of implantable central venous access in children with haemophilia.
MedLine Citation:
PMID:  9753049     Owner:  NLM     Status:  MEDLINE    
To assess the risks associated with the use of central venous ports in children with haemophilia, 15 HIV-negative patients were prospectively evaluated. Port insertion was required for immune tolerance in two inhibitor patients and continuous prophylaxis in 13 patients with severe factor VIII deficiency, for whom surgery was covered with recombinant factor VIII (rFVIII), then given daily at home until day 6. One inhibitor patient (titre 7BU/ml) received high-dose rFVIII by continuous infusion until day 3, followed by an immune tolerance treatment scheme; the other (titre 12 BU/ml) was given recombinant activated factor VII by continuous infusion until day 7. After training on the use of the port, all patients continued their infusion programme at home. All ports remained in place for a median period of 413d (range 125-509). The median number of entries into the port was 184 (range 53-567). Port-site haematoma and infection occurred in one patient on day 7 when an inhibitor became detectable (titre 12 BU/ml). An infectious complication occurred in another patient after 310d. The port infection rate was 0-42 per 1000 patient-days (0.33 per 1000 entries into the port). This protocol for port placement with short hospitalization appears feasible and safe.
E Santagostino; A Gringeri; M Muça-Perja; P M Mannucci
Related Documents :
16451159 - Transarterial block as an addition to a conventional catheter technique improves the ax...
2249119 - Foley catheter balloon puncture and the risk of free fragment formation.
17638269 - Large bore catheters with surface treatments versus untreated catheters for blood access.
10501889 - Routine chest radiographs after central line insertion: mandatory postprocedural evalua...
11428939 - Is vascular reactivity in skin predictable?
7079929 - Technical considerations in the use of intraperitoneal chemotherapy administered by ten...
15573919 - Premedication with tramadol in patients undergoing colonoscopy: a double-blind randomiz...
25081389 - Healing of localized gingival recessions treated with coronally advanced flap alone or ...
17461319 - Arthroscopic anterior cruciate ligament reconstruction using a hamstring graft with int...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  102     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-17     Completed Date:  1998-11-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1224-8     Citation Subset:  IM    
Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, IRCCS Maggiore Hospital and University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bacterial Infections / etiology*
Catheterization, Central Venous / adverse effects*,  instrumentation
Catheters, Indwelling / adverse effects*
Child, Preschool
Factor VIII / administration & dosage*
Follow-Up Studies
Hematoma / etiology
Hemophilia A / blood,  prevention & control*
Hemostasis / physiology
Prospective Studies
Reg. No./Substance:
9001-27-8/Factor VIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Protein Z in healthy human individuals and in patients with a bleeding tendency.
Next Document:  Low-dose aspirin does not lower in vivo platelet activation in healthy smokers.